Ishita Drugs and Industries Limited (ISHITADR.BO)
INR 86.0
(-0.69%)
INR 86.0
(-0.69%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 22.12 Million | -28.97 Million | 30.76 Million | -6.74 Million | 10.47 Million | 7.87 Million |
| Net Income | 7.48 Million | 7.79 Million | 10.42 Million | 10.53 Million | 7.13 Million | 4.62 Million |
| Depreciation & Amortization | 1.11 Million | 1.29 Million | 1.29 Million | 1.46 Million | 1.77 Million | 1.55 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 14.52 Million | -36.59 Million | 19.85 Million | -15.92 Million | 2.84 Million | 2.71 Million |
| Other non-cash items | -11.81 Million | -1.46 Million | -815.71 Thousand | -2.81 Million | -1.27 Million | -1.02 Million |
| Investing Cash Flow | 1.29 Million | 5.94 Million | -9.34 Million | 24.5 Million | -11.53 Million | -10.58 Million |
| Investments in PPE | -268 Thousand | -1.34 Million | -185.41 Thousand | -49.15 Thousand | -145.64 Thousand | -2.67 Million |
| Acquisitions | - | - | -372.15 Thousand | - | - | -940.87 Thousand |
| Investment purchases | - | - | -9.53 Million | - | -12.55 Million | -8.85 Million |
| Sales/Maturities of investments | 574 Thousand | 7.27 Million | 376 Thousand | 21.82 Million | - | 941.07 Thousand |
| Other Investing Activities | 987 Thousand | 13.45 Thousand | 375.54 Thousand | 2.73 Million | 1.16 Million | 941.07 Thousand |
| Financing Cash Flow | -9.6 Million | 10.49 Million | 16.88 Thousand | -2.37 Million | 942.35 Thousand | 866.19 Thousand |
| Debt repayment | -9.6 Million | -9.6 Million | -419.48 Thousand | -2.46 Million | -833.68 Thousand | -779.51 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 1.8 Million | 20.1 Million | 436.37 Thousand | 86.82 Thousand | 1.77 Million | 1.64 Million |
| Accounts receivables | 11.01 Million | -12.58 Million | 9.81 Million | -2.12 Million | -1.3 Million | -3.58 Million |
| Accounts payables | -3.3 Million | -14.29 Million | 13.75 Million | -8.76 Million | 4.47 Million | 7 Million |
| Inventory | 5.34 Million | -6.24 Million | -3.19 Million | -734.94 Thousand | 1.57 Million | -186.86 Thousand |
| Other working capital | 1.47 Million | -3.46 Million | -530.53 Thousand | -4.29 Million | -1.9 Million | -517.41 Thousand |
| Cash at beginning of period | 6.05 Million | 46.81 Million | 25.38 Million | 9.99 Million | 10.11 Million | 11.96 Million |
| Cash at end of period | 48.09 Million | 34.28 Million | 46.81 Million | 25.38 Million | 9.99 Million | 10.11 Million |
| Capital Expenditure | -268 Thousand | -1.34 Million | -185.41 Thousand | -49.15 Thousand | -145.64 Thousand | -2.67 Million |
| Effect of forex changes on cash | - | - | - | -1.00 | 1.00 | -1.00 |
| Net cash flow / Change in cash | 42.04 Million | -12.53 Million | 21.43 Million | 15.38 Million | -114.98 Thousand | -1.85 Million |
| Free Cash Flow | 21.85 Million | -30.31 Million | 30.57 Million | -6.79 Million | 10.32 Million | 5.19 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 7.48 Million | 1.19 Million | 2.1 Million | 1.37 Million | 7.79 Million | 1.78 Million |
| Depreciation & Amortization | 1.11 Million | 333 Thousand | 323.2 Thousand | 343 Thousand | 1.29 Million | 319 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 14.52 Million | - | - | - | -36.59 Million | - |
| Other non-cash items | -11.81 Million | -859 Thousand | -323.2 Thousand | -343 Thousand | -1.46 Million | -319 Thousand |
| Investing Cash Flow | 1.29 Million | - | - | - | 5.94 Million | - |
| Investments in PPE | -268 Thousand | - | - | - | -1.34 Million | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 574 Thousand | - | - | - | 7.27 Million | - |
| Other Investing Activities | 987 Thousand | - | - | - | 13.45 Thousand | - |
| Financing Cash Flow | -9.6 Million | - | - | - | 10.49 Million | - |
| Debt repayment | -9.6 Million | - | - | - | -9.6 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 1.8 Million | - | - | - | 20.1 Million | - |
| Accounts receivables | 11.01 Million | - | - | - | -12.58 Million | - |
| Accounts payables | -3.3 Million | - | - | - | -14.29 Million | - |
| Inventory | 5.34 Million | - | - | - | -6.24 Million | - |
| Other working capital | 1.47 Million | - | - | - | -3.46 Million | - |
| Cash at beginning of period | 6.05 Million | 19.07 Million | 16.96 Million | 6.05 Million | 46.81 Million | 4.26 Million |
| Cash at end of period | 48.09 Million | 19.73 Million | 19.07 Million | 1.37 Million | 34.28 Million | 6.05 Million |
| Capital Expenditure | -268 Thousand | - | - | - | -1.34 Million | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 42.04 Million | 666 Thousand | 2.1 Million | -4.68 Million | -12.53 Million | 1.78 Million |
| Free Cash Flow | 21.85 Million | 666 Thousand | 2.1 Million | 1.37 Million | -30.31 Million | 1.78 Million |
WAGEND
SHREYASI
LAHL
CORE-B
GVFG
POLSON